Columnist Caroline Gainer weighs in on how changes with her doctors have affected her ability to coordinate care for her COPD ...

Fatigue is one of the most common symptoms of COPD, so it's important to understand what causes it, columnist Caroline Gainer says.

Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD ...

To find my sleep sweet spot, I relied on this information and found that going to bed by 10:30 p.m. and getting up at 7:30 a.m. is ideal for me. I read about 20 minutes before I turn off my lamp and ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer ...

While the risk of COPD was highest among traditional cigarette smokers and dual users, e-cigarette users also had a significantly increased risk of COPD over people who’d never used e-cigarettes or ...

Tools to help me survive hard months When I’m feeling down, I like to challenge myself with certain activities that provide an incentive to both exercise and get enough rest. The first challenge I did ...

Let’s not forget the big elephant in the season-change room: allergies. They can cause airway inflammation and worsen COPD symptoms. The best defense against allergens is to avoid them as much as ...

To assess its feasibility, the researchers conducted a pilot study (NCT06000696) involving 100 adults (55 women, 45 men) with COPD who were at risk of needing acute care within the next six months.

COPD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for ...

The Verona Pharma therapy, with a list price of $2,950 for a monthly supply, was cleared by the U.S. Food and Drug Administration in June as an inhaled maintenance therapy for adults with COPD. “We ...